Methods of treatment by administering an anti-BCMA antibody
US7083785B2 · kind B2 · utility
86Cited by
8References
18Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Feb 15, 2002 |
| Grant date | Aug 1, 2006 |
| Priority date | — |
| Expiry date | Jul 6, 2023 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2319/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A novel receptor in the TNF family is provided: BAFF-R. Chimeric molecules and antibodies to BAFF-R and methods of use thereof are also provided.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.